These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 491921)

  • 21. [Action of phenylbutazone on platelet function].
    García-Conde Bru J; Díaz Mayo MC; Benet Monforte IA
    Rev Clin Esp; 1970 Dec; 119(5):421-4. PubMed ID: 5505075
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
    Zaccaria A; Antonini M; Marciani A; Taurino M; Speziale F; Spartera C
    Ric Clin Lab; 1981; 11 Suppl 1():381-6. PubMed ID: 7188126
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical aspects of hemorrheology in the aged: possibility of prevention and therapy].
    Feruglio FS; Ponte E
    Ric Clin Lab; 1981; 11 Suppl 1():373-9. PubMed ID: 7188125
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood coagulation and fibrinolytic system in patients with chronic occlusive peripheral artery disease treated with streptokinase].
    Zola-Sleczek E
    Kardiol Pol; 1973; 16(4):317-22. PubMed ID: 4756966
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug therapy of arterial diseases. A study with Trental 400].
    Tannenberg G
    Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 27. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B; Doppelfeld E
    Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
    Trübestein G; von Bary S; Breddin K; Diehm C; Gruss JD; Heinrich H; Horsch S; Kriessmann A; Maass U; Martin M
    Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombocyte function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 1. Pathogenesis, prevention, therapy].
    Marshall M
    Fortschr Med; 1982 Apr; 100(14):650-5. PubMed ID: 6979499
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of fibrinolysis activation on leukocyte adhesiveness. Preliminary report.
    Lukjan H; Szpak A; Kwiatkowski M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):191-7. PubMed ID: 2427401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical considerations and treatment of diabetic angiopathy.
    Nobbe F
    J Med; 1979; 10(5):365-79. PubMed ID: 393791
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug therapy for peripheral arterial disease.
    Naide D
    Am Fam Physician; 1986 Sep; 34(3):215-7. PubMed ID: 3751848
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
    Chmiel H; Anadere I; Heimburg P
    Ric Clin Lab; 1981; 11 Suppl 1():189-96. PubMed ID: 7188108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of arterial diseases with trental 400. Results of a double-blind study].
    Völker D
    Med Welt; 1978 Aug; 29(32):1244-7. PubMed ID: 672594
    [No Abstract]   [Full Text] [Related]  

  • 37. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged plasma clotting time and decreased fibrinolysis after long term treatment with alpha-tocopherol.
    Korsan-Bengtsen K; Elmfeldt D; Holm T
    Thromb Diath Haemorrh; 1974 Jun; 31(3):505-12. PubMed ID: 4422949
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
    Müller R; Lebrach F
    Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.